Based on these results on gastric adenocarcinoma and since Eg5 has been reported to be overexpressed also in BC [17], kinesin Eg5 inhibitors, along with the parent compound K858, were tested on MCF7 breast adenocarcinoma cell line. The gene discussed is KIF11; the disease is breast adenocarcinoma.